Abstract
Hepatitis B virus (HBV) infected hepatitis is the common infectious disease. In the World Conservative Estimate Plan, the number of persons chronically infected with HBV is more than 300 million. Current regimen of treatment is far from satisfactory, as it is associated with certain side effects and viral resistance capacity. Therefore, a serious attention has recently been paid to the design and development of new potent anti-HBV agents. A variety of drugs have been synthesized and screened for their anti-HBV effects. These include nucleosides, natural compounds, quinolines, benzodiazepines, indoles, etc. Many of them are in wide trend in current treatment regimen. In this review, we have presented the recent development on the design and development of all categories of HBV inhibitors studied.
Keywords: Anti-hepatitis B virus agents, nucleosides, quinolines, benzodiazepines, indoles, Anti-Hepatitis B, Virus, (HBV), STERIMOL parameter, surface antigen, nucleocapsid core antigen, pre-core antigen, HBV replication, DNA polymerase, DNA, RNA, Chronic Hepatitis, Active prophylaxis, Passive Immunization, Interferon, Immunomodulators, Adoptive Immune Transfer, Nucleoside Analogs, thrombocytopenia, anemia, DHBV, famciclovir, Sophora flavescens, X-ray analysis, Hypserpa nitida, Alisma orientalis, replication, Inhi-bition assay, BENZODIAZEPINESINDOL, lamivudine, (QSAR)
Current Medicinal Chemistry
Title: Design and Development of Anti-Hepatitis B Virus Agents
Volume: 17 Issue: 29
Author(s): S. Kaushik, S. P. Gupta and P. K. Sharma
Affiliation:
Keywords: Anti-hepatitis B virus agents, nucleosides, quinolines, benzodiazepines, indoles, Anti-Hepatitis B, Virus, (HBV), STERIMOL parameter, surface antigen, nucleocapsid core antigen, pre-core antigen, HBV replication, DNA polymerase, DNA, RNA, Chronic Hepatitis, Active prophylaxis, Passive Immunization, Interferon, Immunomodulators, Adoptive Immune Transfer, Nucleoside Analogs, thrombocytopenia, anemia, DHBV, famciclovir, Sophora flavescens, X-ray analysis, Hypserpa nitida, Alisma orientalis, replication, Inhi-bition assay, BENZODIAZEPINESINDOL, lamivudine, (QSAR)
Abstract: Hepatitis B virus (HBV) infected hepatitis is the common infectious disease. In the World Conservative Estimate Plan, the number of persons chronically infected with HBV is more than 300 million. Current regimen of treatment is far from satisfactory, as it is associated with certain side effects and viral resistance capacity. Therefore, a serious attention has recently been paid to the design and development of new potent anti-HBV agents. A variety of drugs have been synthesized and screened for their anti-HBV effects. These include nucleosides, natural compounds, quinolines, benzodiazepines, indoles, etc. Many of them are in wide trend in current treatment regimen. In this review, we have presented the recent development on the design and development of all categories of HBV inhibitors studied.
Export Options
About this article
Cite this article as:
Kaushik S., P. Gupta S. and K. Sharma P., Design and Development of Anti-Hepatitis B Virus Agents, Current Medicinal Chemistry 2010; 17 (29) . https://dx.doi.org/10.2174/092986710793176375
DOI https://dx.doi.org/10.2174/092986710793176375 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advanced Techniques for Penetration Enhancement in Transdermal Drug Delivery System
Current Drug Delivery Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers
Recent Patents on Anti-Infective Drug Discovery Meet Our Associate Editor
Current Molecular Medicine Physiological and Comparative Evidence Fails to Confirm an Adaptive Role for Aging in Evolution
Current Aging Science DNA Mismatch Repair Deficiency, Resistance to Cancer Chemotherapy and the Development of Hypersensitive Agents
Current Topics in Medicinal Chemistry Circulating MicroRNAs as a New Class of Biomarkers of Physiological Reactions of the Organism to the Intake of Dietary Supplements and Drugs
MicroRNA Does in vitro Fertilisation Increase Type 2 Diabetes and Cardiovascular Risk?
Current Diabetes Reviews Hippocampal Morphology and Autobiographic Memory in Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Host Pharmacogenetics in the Treatment of HIV and Cancer
Current Drug Safety Pharmacogenomics
Current Drug Metabolism Nucleoside Transporter Proteins
Current Vascular Pharmacology Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Current Gene Therapy The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction
Current Pharmaceutical Design Genetic Predisposition to Neonatal Tumors
Current Pediatric Reviews Diet and Metabolic Syndrome: An Overview
Current Vascular Pharmacology Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism
Current Drug Targets On the Power of Additional and Complex Chromosomal Aberrations in CML
Current Genomics RNAi in Clinical Studies
Current Medicinal Chemistry Rare Germline <i>GLMN</i> Variants Identified from Blue Rubber Bleb Nevus Syndrome Might Impact mTOR Signaling
Combinatorial Chemistry & High Throughput Screening The Nutrigenetics and Pharmacogenetics of Vitamin D Pathways
Current Pharmacogenomics and Personalized Medicine